CDKN2A and non-small cell lung carcinoma: Specifically, we observed similar comutation patterns between KRASG12C- and KRASnon-G12C-mutant NSCLC for key oncogenes LRP1B, STK11, KEAP1, and CDKN2A but a lower comutation rate with TP53.